Tuesday, U.S. Sens. Bernie Sanders (I-VT) and Bill Cassidy (R-LA) announced plans to hold an official markup session to discuss proposed legislation for lowering drug prices. The hearing is scheduled for May 2.
Contaminated cough syrup made by an Indian company has been found in the Marshall Islands and Micronesia, the World Health Organization (WHO) said on Tuesday, after a spate of child deaths linked to other syrups in some countries last year.
Operation Warp Speed worked so well to accelerate the development of COVID-19 vaccines the FDA now has its sights set on a similar initiative for rare disease treatments.
The U.S. Supreme Court on Friday blocked new restrictions set by lower courts on a widely used abortion pill, a decision welcomed by President Joe Biden as his administration defends broad access to the drug in the latest fierce legal battle over reproductive rights in the United States.
U.S. Supreme Court Justice Samuel Alito on Wednesday extended by two days a temporary block on limits set by lower courts on access to the abortion pill mifepristone in a challenge by anti-abortion groups to the drug’s federal regulatory approval.
Abbott Laboratories reported quarterly profit above expectations on Wednesday, underpinned by sales of its diabetes care devices and an improved demand for other devices due to a resumption in non-urgent medical procedures.
Hundreds of GSK workers have voted to stage a series of walkouts at UK manufacturing sites in May over a dispute over pay, in what could be a first at the British drugmaker, labour union Unite said on Wednesday.
Argentina, fighting one of its worst outbreaks of dengue in recent years, is sterilizing mosquitoes using radiation that alters their DNA before releasing them into the wild.
ReutersE-cigarette company Juul Labs Inc and its former largest investor, Marlboro maker Altria Group Inc., on Monday settled claims by the state of Minnesota that they fueled teen vaping addiction.
The U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp.’s bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China’s HEC Pharm Co. Ltd.
